癌症患者与一般人群健康效用值的差异:以 SF-6Dv2 为例对魁北克的分析

Differences in health utilities between cancer patients and the general population: The case of Quebec using the SF-6Dv2.

机构信息

Department of Economics, Business School, Université de Sherbrooke, Sherbrooke, QC, Canada; Centre de Recherche de l'IUSMM, CIUSSS de l'Est de l'Île de Montréal, Montréal, QC, Canada.

Centre de Recherche de l'IUSMM, CIUSSS de l'Est de l'Île de Montréal, Montréal, QC, Canada; Department of Management, Evaluation and Health Policy, School of Public Health, Université de Montréal, Montréal, QC, Canada; Centre de recherche du CHUS, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.

出版信息

Soc Sci Med. 2024 Jun;351:117001. doi: 10.1016/j.socscimed.2024.117001. Epub 2024 May 18.

Abstract

A considerable debate persists in the literature about whose preferences should be considered in the calculation of quality-adjusted life-years. Some suggest considering only the preferences of the general population, while others advocate for the consideration of those of patients or a combination of both. This study aims to inform and measure the differences in health preferences between cancer patients and the general population in Quebec. A total of 60,976 observations representing the preferences of the general population for various health states were collected and used to develop a new value set using the SF-6Dv2. This value set was generated by combining 34,299 observations with time trade-off (TTO) and 26,677 observations with discrete choice experiment (DCE). Utility scores derived from this value set were compared to those of patients' preferences from a new value set in breast and colorectal patients for the SF-6Dv2. For both patients and the general population, the 'Pain' dimension was the highest contributor to the utility score. However, noticeable differences were observed in the estimates. Estimates of levels 2 and 3 were generally lower for cancer patients, while they were more likely to have greater estimates in severe levels. Significant differences in utility scores were also noticed with the general population showing higher mean utility scores for the same health states. These differences increased as the health states worsened. This study sheds light on the existing differences in preferences between cancer patients and the general population of Quebec for a better consideration in healthcare decision-making.

摘要

关于在计算质量调整生命年时应考虑谁的偏好,文献中存在相当大的争议。一些人建议只考虑普通人群的偏好,而另一些人则主张考虑患者的偏好或两者的结合。本研究旨在为魁北克的癌症患者和普通人群的健康偏好差异提供信息和衡量。共收集了 60976 个观察结果,代表普通人群对各种健康状况的偏好,用于使用 SF-6Dv2 开发新的价值集。该价值集通过结合 34299 个具有时间权衡 (TTO) 的观察结果和 26677 个具有离散选择实验 (DCE) 的观察结果生成。从这个价值集中得出的效用得分与来自新价值集中的乳腺癌和结直肠癌患者的 SF-6Dv2 的患者偏好进行了比较。对于患者和普通人群,“疼痛”维度是对效用得分的最大贡献者。然而,观察到的估计值存在明显差异。癌症患者的 2 级和 3 级估计值通常较低,而他们在严重水平上更有可能有更大的估计值。在效用得分方面也观察到了显著差异,普通人群在相同的健康状况下表现出更高的平均效用得分。这些差异随着健康状况的恶化而增加。这项研究揭示了魁北克癌症患者和普通人群之间在偏好方面的现有差异,以便在医疗保健决策中更好地考虑这些差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索